Luo Jiang

711 total citations
29 papers, 553 citations indexed

About

Luo Jiang is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Luo Jiang has authored 29 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Luo Jiang's work include Cancer, Lipids, and Metabolism (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Phytochemistry and biological activity of medicinal plants (3 papers). Luo Jiang is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Phytochemistry and biological activity of medicinal plants (3 papers). Luo Jiang collaborates with scholars based in China, Argentina and Japan. Luo Jiang's co-authors include Rui Hou, Zhaohong Wang, Heqi Bu, Sheng‐Zhang Lin, Qi‐Jun Wu, Hongfei Tong, Jianhong Zhang, Ting‐Ting Gong, Hui Chen and Aimin Zhang and has published in prestigious journals such as Scientific Reports, Polymer and Building and Environment.

In The Last Decade

Luo Jiang

27 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luo Jiang China 15 247 84 70 50 45 29 553
Yao Wu China 14 299 1.2× 99 1.2× 64 0.9× 22 0.4× 60 1.3× 29 526
Shixin Chen China 16 323 1.3× 89 1.1× 52 0.7× 55 1.1× 40 0.9× 74 806
Chanchal Gupta India 11 167 0.7× 57 0.7× 69 1.0× 29 0.6× 26 0.6× 20 414
Qiuju Huang China 16 370 1.5× 76 0.9× 57 0.8× 58 1.2× 66 1.5× 47 696
Xiang Yang China 14 445 1.8× 63 0.8× 100 1.4× 40 0.8× 25 0.6× 23 807
Yuhong Sun China 13 238 1.0× 80 1.0× 124 1.8× 25 0.5× 30 0.7× 25 576
Sufeng Zhou China 14 256 1.0× 34 0.4× 149 2.1× 43 0.9× 28 0.6× 49 751
Pushkar Singh Rawat India 5 255 1.0× 53 0.6× 154 2.2× 33 0.7× 16 0.4× 8 657
Dipita Bhakta-Guha India 10 376 1.5× 109 1.3× 209 3.0× 41 0.8× 68 1.5× 18 761
Babbak Shahandeh United States 4 194 0.8× 58 0.7× 94 1.3× 44 0.9× 15 0.3× 5 417

Countries citing papers authored by Luo Jiang

Since Specialization
Citations

This map shows the geographic impact of Luo Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luo Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luo Jiang more than expected).

Fields of papers citing papers by Luo Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luo Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luo Jiang. The network helps show where Luo Jiang may publish in the future.

Co-authorship network of co-authors of Luo Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Luo Jiang. A scholar is included among the top collaborators of Luo Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luo Jiang. Luo Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ai, Zhengtao, et al.. (2025). Characteristics and health risks of PM2.5 and VOCs in multi-chair dental offices: A case study in central China. Building and Environment. 289. 114110–114110.
2.
Yang, Ran, Huijuan Wu, Xinyu Liu, et al.. (2025). Cisplatin-encapsulated zeolitic imidazolate framework-8 nanosystem enhanced radiosensitivity of non-small cell lung cancer. Scientific Reports. 15(1). 42758–42758.
3.
Jiang, Luo, Ting‐Ting Gong, Song Gao, et al.. (2021). Pre-diagnosis Dairy Product Intake and Ovarian Cancer Mortality: Results From the Ovarian Cancer Follow-Up Study (OOPS). Frontiers in Nutrition. 8. 750801–750801. 12 indexed citations
4.
Jiang, Luo & Rui Hou. (2020). <p>Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway</p>. OncoTargets and Therapy. Volume 13. 3631–3639. 17 indexed citations
5.
Yang, Hua, et al.. (2020). Ultrasonographic Imaging Features of Female Urethral and Peri-urethral Masses: A Retrospective Study of 95 Patients. Ultrasound in Medicine & Biology. 46(8). 1896–1907. 5 indexed citations
6.
Hou, Rui, Zhuo Yang, Shizhuo Wang, et al.. (2017). miR-762 can negatively regulate menin in ovarian cancer. OncoTargets and Therapy. Volume 10. 2127–2137. 26 indexed citations
7.
Hou, Rui, Luo Jiang, Dawo Liu, et al.. (2017). Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression. International Journal of Molecular Medicine. 40(2). 293–302. 14 indexed citations
8.
Pu, Chunlan, Rong‐Hua Luo, Mengqi Zhang, et al.. (2017). Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(17). 4150–4155. 12 indexed citations
9.
Hou, Rui, Luo Jiang, Zhuo Yang, Shizhuo Wang, & Qifang Liu. (2016). Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway. Tumor Biology. 37(12). 16005–16013. 22 indexed citations
10.
Han, Xuan, Luo Jiang, Feng Wu, et al.. (2016). Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents. European Journal of Medicinal Chemistry. 114. 232–243. 30 indexed citations
11.
Jiang, Luo, Rui Hou, Ting‐Ting Gong, & Qi‐Jun Wu. (2015). Dietary fat intake and endometrial cancer risk: dose-response meta-analysis of epidemiological studies. Scientific Reports. 5(1). 16693–16693. 20 indexed citations
12.
Chen, Hui, Jianhong Zhang, Luo Jiang, et al.. (2013). Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Oncology Reports. 30(2). 589–595. 56 indexed citations
13.
Zhang, Wei, Hui Chen, DIAN-LEI LIU, et al.. (2013). Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets. International Journal of Oncology. 42(4). 1189–1196. 38 indexed citations
14.
Huang, Ying, Da Liu, Luo Jiang, et al.. (2013). Quantitative Assessment of Bladder Neck Compliance by Using Transvaginal Real-Time Elastography of Women. Ultrasound in Medicine & Biology. 39(10). 1727–1734. 7 indexed citations
15.
Li, Jing, et al.. (2012). Pathological basis of breast cancer malignant halo on ultrasound. Zhonghua chaosheng yingxiangxue zazhi. 21(9). 787–790. 1 indexed citations
16.
Huang, Ying, Da Liu, Luo Jiang, & Shoujun Liu. (2012). Assessment of Cystitis Glandularis by Transvaginal Sonography in Women. Journal of Ultrasound in Medicine. 31(7). 1025–1031. 3 indexed citations
17.
18.
Bu, Heqi, Luo Jiang, Hui Chen, et al.. (2012). Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. International Journal of Oncology. 41(3). 949–958. 34 indexed citations
19.
Liu, Jinxiang, Jianhong Zhang, Honghai Li, et al.. (2012). Emodin induces Panc-1 cell apoptosis via declining the mitochondrial membrane potential. Oncology Reports. 28(6). 1991–1996. 28 indexed citations
20.
Jiang, Luo, Miao Sun, Yang Luo, et al.. (2006). Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. British Journal of Dermatology. 154(4). 636–642. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Wu Breakdown of academic impact, for papers by Shixin Chen Breakdown of academic impact, for papers by Chanchal Gupta Breakdown of academic impact, for papers by Qiuju Huang Breakdown of academic impact, for papers by Xiang Yang Breakdown of academic impact, for papers by Yuhong Sun Breakdown of academic impact, for papers by Sufeng Zhou Breakdown of academic impact, for papers by Pushkar Singh Rawat Breakdown of academic impact, for papers by Dipita Bhakta-Guha Breakdown of academic impact, for papers by Babbak Shahandeh
Rankless by CCL
2026